Clinical Trial Update: Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 study evaluating the combination of Bacillus Calmette-Guérin (BCG) and Gemcitabine in patients with high-grade non-muscle …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-Muscle Invasive Bladder Cancer (NMIBC) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING